Yang Yang, Fan Songqing
Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Chin Med J Pulm Crit Care Med. 2024 Feb 6;2(1):42-47. doi: 10.1016/j.pccm.2023.10.005. eCollection 2024 Mar.
Lung cancer is a leading cause of cancer deaths worldwide, consisting of two major histological subtypes: small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). In some cases, NSCLC patients may undergo a histological transformation to SCLC during clinical treatments, which is associated with resistance to targeted therapy, immunotherapy, or chemotherapy. The review provides a comprehensive analysis of SCLC transformation from NSCLC, including biological mechanism, clinical relevance, and potential treatment options after transformation, which may give a better understanding of SCLC transformation and provide support for further research to define better therapy options.
肺癌是全球癌症死亡的主要原因,由两种主要的组织学亚型组成:小细胞肺癌(SCLC)和非小细胞肺癌(NSCLC)。在某些情况下,NSCLC患者在临床治疗期间可能会发生组织学转化为SCLC,这与对靶向治疗、免疫治疗或化疗的耐药性有关。这篇综述对NSCLC向SCLC的转化进行了全面分析,包括生物学机制、临床相关性以及转化后的潜在治疗选择,这可能有助于更好地理解SCLC转化,并为进一步研究以确定更好的治疗方案提供支持。